X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
benzazepines - pharmacology (5884) 5884
animals (5873) 5873
male (4779) 4779
rats (3564) 3564
humans (2152) 2152
pharmacology & pharmacy (1948) 1948
neurosciences (1678) 1678
female (1615) 1615
dopamine antagonists - pharmacology (1386) 1386
dose-response relationship, drug (1324) 1324
dopamine (1195) 1195
rats, sprague-dawley (1138) 1138
mice (1040) 1040
benzazepines - therapeutic use (970) 970
receptors, dopamine - drug effects (838) 838
rats, inbred strains (820) 820
dopamine agonists - pharmacology (800) 800
receptors, dopamine d1 - antagonists & inhibitors (782) 782
motor activity - drug effects (690) 690
in vitro techniques (683) 683
receptors, dopamine d1 - metabolism (683) 683
rats, wistar (680) 680
adult (678) 678
benzazepines - administration & dosage (677) 677
middle aged (631) 631
time factors (625) 625
benzazepines - metabolism (622) 622
behavior, animal - drug effects (590) 590
sulpiride - pharmacology (573) 573
2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine - pharmacology (549) 549
dopamine - metabolism (541) 541
heart rate - drug effects (536) 536
receptors (523) 523
rat (502) 502
corpus striatum - metabolism (492) 492
receptors, dopamine d1 (490) 490
blood pressure - drug effects (477) 477
dopamine antagonists (454) 454
receptors, dopamine d1 - physiology (454) 454
sch 23390 (446) 446
corpus striatum - drug effects (445) 445
psychiatry (436) 436
dopamine - pharmacology (434) 434
dogs (432) 432
drug interactions (421) 421
haloperidol - pharmacology (418) 418
receptors, dopamine - physiology (418) 418
dopamine d2 receptor antagonists (413) 413
receptors, dopamine - metabolism (411) 411
quinpirole (408) 408
diltiazem - pharmacology (401) 401
brain (399) 399
receptors, dopamine d1 - drug effects (395) 395
dopamine receptors (390) 390
aged (388) 388
dopamine agents - pharmacology (385) 385
apomorphine - pharmacology (372) 372
varenicline (370) 370
benzazepines - adverse effects (367) 367
dopamine - physiology (356) 356
ergolines - pharmacology (356) 356
receptors, dopamine d1 - agonists (352) 352
nucleus-accumbens (337) 337
receptors, dopamine d2 - metabolism (336) 336
receptor (326) 326
salicylamides - pharmacology (325) 325
kinetics (315) 315
receptors, dopamine d2 (315) 315
cocaine (313) 313
neurons (307) 307
biochemistry & molecular biology (300) 300
striatum (300) 300
analysis of variance (296) 296
benzazepines - pharmacokinetics (294) 294
neurons - drug effects (294) 294
2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine (293) 293
brain - metabolism (290) 290
brain - drug effects (285) 285
disease models, animal (282) 282
expression (279) 279
cocaine - pharmacology (278) 278
behavioral sciences (266) 266
rabbits (261) 261
benzazepines - chemical synthesis (258) 258
antidiuretic hormone receptor antagonists (257) 257
benzazepines - chemistry (256) 256
reward (256) 256
nucleus accumbens - drug effects (255) 255
structure-activity relationship (253) 253
raclopride (249) 249
cardiac & cardiovascular systems (248) 248
treatment outcome (245) 245
receptors, dopamine d2 - drug effects (244) 244
hemodynamics - drug effects (240) 240
autoradiography (238) 238
mice, inbred c57bl (238) 238
conditioning, operant - drug effects (236) 236
sch-23390 (234) 234
analysis (233) 233
amphetamine (225) 225
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7345) 7345
Japanese (171) 171
German (73) 73
Russian (47) 47
Chinese (32) 32
Italian (31) 31
French (30) 30
Spanish (10) 10
Polish (6) 6
Czech (2) 2
Norwegian (2) 2
Dutch (1) 1
Finnish (1) 1
Hungarian (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropsychopharmacology (New York, N.Y.), ISSN 1740-634X, 2008, Volume 34, Issue 3, pp. 681 - 697
Psychopharmacological studies have implicated the mesolimbic dopamine (DA) system in the mediation of cost/benefit evaluations about delay or effort-related... 
Discounting | Gambling | Amphetamine | Parkinson's disease | receptors | D-1 RECEPTOR | PSYCHIATRY | discounting | amphetamine | gambling | NEUROCHEMICAL PROFILE | NORMAL VOLUNTEERS | NEUROSCIENCES | VENTROMEDIAL PREFRONTAL CORTEX | D-2 receptors | IMPULSIVE BEHAVIOR | D-3 receptors | PHARMACOLOGY & PHARMACY | RECEPTOR GENE | D-AMPHETAMINE | PROBABILISTIC REINFORCEMENT | WORKING-MEMORY | PARKINSONS-DISEASE | Receptors, Dopamine D4 - agonists | Rats, Long-Evans | Decision Making - drug effects | Risk | Receptors, Dopamine D4 - antagonists & inhibitors | Pyrrolidines - pharmacology | Conditioning, Operant - drug effects | Receptors, Dopamine D1 - agonists | Behavior, Animal - drug effects | Benzamides - pharmacology | Benzopyrans - pharmacology | Receptors, Dopamine D3 - antagonists & inhibitors | Oxazines - pharmacology | Receptors, Dopamine D1 - antagonists & inhibitors | Dopamine Agonists - pharmacology | Dextroamphetamine - pharmacology | Receptors, Dopamine D2 - agonists | Rats | Behavior, Animal - physiology | Bromocriptine - pharmacology | Benzazepines - pharmacology | Piperazines - pharmacology | Naphthalenes - pharmacology | Receptors, Dopamine D3 - agonists | Reinforcement Schedule | Pyrroles - pharmacology | Animals | Dopamine Antagonists - pharmacology | Decision Making - physiology | Pyridines - pharmacology | Dopamine D2 Receptor Antagonists | Salicylamides - pharmacology
Journal Article
Biochemical journal, ISSN 1470-8728, 2003, Volume 371, Issue 1, pp. 199 - 204
We have previously examined the specificities of 28 commercially available compounds, reported to be relatively selective inhibitors of particular... 
SELECTIVE-INHIBITION | ACTIVATION | VIVO | Src | protein kinase inhibitors | TYROSINE KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | protein phosphorylation | CYCLIN-DEPENDENT KINASES | GLYCOGEN-SYNTHASE KINASE-3-BETA | IN-VITRO | POTENT | SP 600125 | Roscovitine | Kenpaullone | LITHIUM | SMOOTH-MUSCLE CELLS
Journal Article
Neuropsychopharmacology (New York, N.Y.), ISSN 1740-634X, 2009, Volume 34, Issue 10, pp. 2329 - 2343
Journal Article
Neuropharmacology, ISSN 0028-3908, 2014, Volume 87, pp. 206 - 213
There has been a dramatic rise in the abuse of synthetic cathinones known as “bath salts,” including 3,4-methylenedioxypyrovalerone (MDPV), an analog linked to... 
3,4-Methylenedioxypyrovalerone | Synthetic cathinones | α-PVP | Locomotor activity | Functional observational battery | Monoamine transporter | ANALOGS | RATS | LOCOMOTOR-ACTIVITY | MEPHEDRONE | CATHINONE DERIVATIVES | MONOAMINE TRANSPORTERS | NEUROSCIENCES | INTOXICATION | alpha-PVP | IN-VITRO | DOPAMINE | PHARMACOLOGY & PHARMACY | 2ND-GENERATION LEGAL HIGHS | Dopamine Plasma Membrane Transport Proteins - metabolism | Synaptosomes - drug effects | Central Nervous System Stimulants - pharmacology | Motor Activity - drug effects | Male | Synaptosomes - metabolism | Pyrrolidines - pharmacology | Dose-Response Relationship, Drug | Benzodioxoles - chemistry | Locomotion - drug effects | Designer Drugs - pharmacology | Catecholamine Plasma Membrane Transport Proteins - metabolism | Brain - physiopathology | Catecholamine Plasma Membrane Transport Proteins - antagonists & inhibitors | Benzazepines - pharmacology | Random Allocation | Pyrrolidines - chemistry | Rats, Sprague-Dawley | Mice, Inbred ICR | Brain - drug effects | Designer Drugs - chemistry | Animals | Dopamine Antagonists - pharmacology | Central Nervous System Stimulants - chemistry | Norepinephrine Plasma Membrane Transport Proteins - metabolism | Street Drugs - pharmacology | Benzodioxoles - pharmacology | RNA-Binding Proteins - metabolism | Street Drugs - chemistry | Bath products | Resveratrol | monoamine transporter | locomotor activity | 3,4-methylenedioxypyrovalerone | functional observational battery | synthetic cathinones
Journal Article
Annual review of pharmacology and toxicology, ISSN 1545-4304, 2009, Volume 49, Issue 1, pp. 57 - 71
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 12/2010, Volume 335, Issue 3, pp. 807 - 816
Accumulating evidence suggests that acetylcholine nicotinic systems may contribute importantly to the abuse-related effects of d-methamphetamine (d-MA). The... 
DIHYDRO-BETA-ERYTHROIDINE | DOPAMINE RELEASE | BEHAVIORAL SENSITIZATION | SEEKING BEHAVIOR | COCAINE | PHARMACOLOGY & PHARMACY | MONOAMINE TRANSPORTERS | STIMULUS PROPERTIES | BINDING-SITES | NUCLEUS-ACCUMBENS | UPTAKE INHIBITORS | Nicotinic Antagonists - administration & dosage | Cholinergic Agents - administration & dosage | Cholinergic Agents - pharmacology | Varenicline | Pentobarbital - administration & dosage | Pentobarbital - pharmacology | Male | Nicotinic Antagonists - pharmacology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Drug Interactions | Muscarinic Antagonists - pharmacology | Discrimination (Psychology) | Mecamylamine - pharmacology | Behavior, Animal - drug effects | Nicotinic Agonists - pharmacology | Discrimination Learning | Methamphetamine - pharmacology | Dopamine Agonists - pharmacology | Mecamylamine - administration & dosage | Dextroamphetamine - pharmacology | Quinoxalines - administration & dosage | Reinforcement (Psychology) | Rats | Benzazepines - pharmacology | Rats, Sprague-Dawley | Muscarinic Antagonists - administration & dosage | Nicotinic Agonists - administration & dosage | Animals | Cholinesterase Inhibitors - administration & dosage | Cholinesterase Inhibitors - pharmacology | Methamphetamine - administration & dosage | Dopamine Agonists - administration & dosage | Conditioning, Operant | Benzazepines - administration & dosage | Dextroamphetamine - administration & dosage
Journal Article